The Russians spent more than 64 billion rubles. for medicines for COVID-19

Russians in 2021, according to the unified system of digital marking and tracking of goods "Honest Sign", spent more than 64 billion rubles. for drugs against CORONAVIRUS, RBC was told at the Center for the Development of Advanced Technologies (CRPT).

Citizens spent most of all on the antiviral drug umifenovir (16.8 billion rubles), the immunomodulator interferon-alpha-2b (7.2 billion rubles), the drug for the treatment of covid-19 favipiravir (2.9 billion rubles), the antibiotic dexamethasone (1 billion rubles), as well as methylprednisolone (0.8 billion rubles).

Muscovites and residents of the Moscow Region (5 billion rubles each) and the Krasnodar Territory (3 billion rubles) incurred the greatest expenses.

In total, 144 million packages of drugs recommended for the treatment of COVID-19 were sold in the country.